Survival Outcomes from Atezolizumab plus Bevacizumab Versus Lenvatinib Versus Sorafenib in Child Pugh B Unresectable Hepatocellular Carcinoma Patients
AuthID
P-00Z-67F
P-00Z-67F
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service